Based on research at Stanford, Bluestar Genomics is working on a non-invasive test for pancreatic cancer.

Vanderbilt’s Center for Technology Transfer and Commercialization generated nine new companies in 2020 and licensed a significant number of covid-related technologies.

Short-term accommodation provider Cohabs secured more than $70m in a round led by AG Real Estate, while Stampli, Impress and Tarana Wireless each raised $50m.

Weizmann Institute of Science participated in a series B round for its spinout that was originally known as OnSight Medical.

The health data analytics provider counts Johnson & Johnson, McKesson, Amgen, Sanofi, UCB Pharma and Blue Cross Blue Shield of New Jersey as earlier investors.

Human resources software provider Legion and edge cloud services provider Zenlayer each received $50m while Intel is exiting Sedona Systems in a $100m acquisition.

Bayer, Hitachi, Samsung, Sony and Unilever participated in a series C round for the healthcare monitoring technology provider valuing it near to $1bn.

Appia Bio has emerged from stealth with $52m in series A financing to commercialise cancer treatments based on research at UCLA.

Atlantic Bridge has launched the University Bridge Fund II, with University College Cork joining existing partners Trinity College Dublin and University College Dublin.

Bertelsmann helped crypto financial service provider Babel Finance close a $40m series A round while Blind raised $37m from investors including Cisco.